Wedbush Maintains Neutral on Healthcare Realty Trust, Raises Price Target to $18
Portfolio Pulse from Benzinga Newsdesk
Wedbush analyst Richard Anderson maintains a Neutral rating on Healthcare Realty Trust (NYSE:HR) and raises the price target from $15 to $18.
August 05, 2024 | 6:33 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wedbush analyst Richard Anderson maintains a Neutral rating on Healthcare Realty Trust and raises the price target from $15 to $18.
The raised price target from $15 to $18 suggests a positive outlook for Healthcare Realty Trust, which could lead to a short-term increase in stock price. However, the Neutral rating indicates that the stock may not outperform the market significantly.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100